The DolorClast® iPad app is the reference in Radial Extracorporeal Shock Wave Therapy and features the Original Swiss DolorClast® Method invented by EMS Electro Medical Systems of Nyon, Switzerland.

Now available in 7 different languages - English, German, French, Spanish, Italian, Portuguese and Russian -, this app is an all-in-one educational and therapeutic guide.
The update includes a unique VAS pain scale measuring patients’ pain intensity. The app also provides medical descriptions, contraindications, treatment protocols, clinical reference studies and treatment videos for 17 conditions including chronic tendinopathies of the musculoskeletal system such as plantar fasciopathy or Achilles insertional tendinopathy.

Other pathologies affecting the skin such as acute and chronic soft tissue wounds, primary and secondary lymphedema and cellulite are also covered.

You will also find some general information about Radial Extracorporeal Shock Wave technology and its beneficial effects as well as a brief description of the entire range of Swiss DolorClast® products.

This complete application is perfect to update shock wave users on the latest developments and for educating patients concerning the Swiss DolorClast® Method.

All you need to know about Radial Extracorporeal Shock Wave Therapy is available in one concise app !
Read more
Collapse
4.0
8 total
5
4
3
2
1
Loading…

What's New

Lighter code - More secure about dependancies - Solves the false positive security flag in some antivirus apps. 64 Bit compliant - SDK > 5 for better compatibility with new tablets
Read more
Collapse

Additional Information

Updated
January 20, 2020
Size
16M
Installs
500+
Current Version
2.3.4
Requires Android
4.4 and up
Content Rating
Everyone
Permissions
Offered By
E.M.S Electro Medical Systems SA
©2020 GoogleSite Terms of ServicePrivacyDevelopersArtistsAbout Google|Location: United StatesLanguage: English
By purchasing this item, you are transacting with Google Payments and agreeing to the Google Payments Terms of Service and Privacy Notice.